QQQ   432.23 (+0.27%)
AAPL   169.56 (-1.81%)
MSFT   416.66 (+0.73%)
META   502.49 (+0.45%)
GOOGL   154.93 (+0.05%)
AMZN   184.08 (+0.25%)
TSLA   157.09 (-2.72%)
NVDA   876.46 (+1.91%)
AMD   163.77 (+2.15%)
NIO   3.84 (-1.29%)
BABA   70.02 (-0.85%)
T   16.04 (-1.23%)
F   12.21 (-0.16%)
MU   121.46 (+0.07%)
GE   155.81 (+1.37%)
CGC   6.86 (-1.72%)
DIS   114.23 (+1.13%)
AMC   2.80 (+13.36%)
PFE   25.80 (-0.42%)
PYPL   63.98 (+0.74%)
XOM   118.71 (-0.81%)
QQQ   432.23 (+0.27%)
AAPL   169.56 (-1.81%)
MSFT   416.66 (+0.73%)
META   502.49 (+0.45%)
GOOGL   154.93 (+0.05%)
AMZN   184.08 (+0.25%)
TSLA   157.09 (-2.72%)
NVDA   876.46 (+1.91%)
AMD   163.77 (+2.15%)
NIO   3.84 (-1.29%)
BABA   70.02 (-0.85%)
T   16.04 (-1.23%)
F   12.21 (-0.16%)
MU   121.46 (+0.07%)
GE   155.81 (+1.37%)
CGC   6.86 (-1.72%)
DIS   114.23 (+1.13%)
AMC   2.80 (+13.36%)
PFE   25.80 (-0.42%)
PYPL   63.98 (+0.74%)
XOM   118.71 (-0.81%)
QQQ   432.23 (+0.27%)
AAPL   169.56 (-1.81%)
MSFT   416.66 (+0.73%)
META   502.49 (+0.45%)
GOOGL   154.93 (+0.05%)
AMZN   184.08 (+0.25%)
TSLA   157.09 (-2.72%)
NVDA   876.46 (+1.91%)
AMD   163.77 (+2.15%)
NIO   3.84 (-1.29%)
BABA   70.02 (-0.85%)
T   16.04 (-1.23%)
F   12.21 (-0.16%)
MU   121.46 (+0.07%)
GE   155.81 (+1.37%)
CGC   6.86 (-1.72%)
DIS   114.23 (+1.13%)
AMC   2.80 (+13.36%)
PFE   25.80 (-0.42%)
PYPL   63.98 (+0.74%)
XOM   118.71 (-0.81%)
QQQ   432.23 (+0.27%)
AAPL   169.56 (-1.81%)
MSFT   416.66 (+0.73%)
META   502.49 (+0.45%)
GOOGL   154.93 (+0.05%)
AMZN   184.08 (+0.25%)
TSLA   157.09 (-2.72%)
NVDA   876.46 (+1.91%)
AMD   163.77 (+2.15%)
NIO   3.84 (-1.29%)
BABA   70.02 (-0.85%)
T   16.04 (-1.23%)
F   12.21 (-0.16%)
MU   121.46 (+0.07%)
GE   155.81 (+1.37%)
CGC   6.86 (-1.72%)
DIS   114.23 (+1.13%)
AMC   2.80 (+13.36%)
PFE   25.80 (-0.42%)
PYPL   63.98 (+0.74%)
XOM   118.71 (-0.81%)
Free Trial

Lexicon Pharmaceuticals (LXRX) Earnings Date, Estimates & Call Transcripts

→ Can't believe it's happening again (From Manward Press) (Ad)
Free LXRX Stock Alerts
$1.82
-0.05 (-2.67%)
(As of 01:27 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media

Earnings Summary

Upcoming
Earnings Date
May. 7Estimated
Actual EPS
(Mar. 11)
-$0.20 Beat By $0.03
Consensus EPS
(Mar. 11)
-$0.23
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

LXRX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

LXRX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Lexicon Pharmaceuticals Analyst EPS Estimates

Current Year EPS Consensus Estimate:($0.71) EPS
Next Year EPS Consensus Estimate: ($0.66) EPS

LXRX Earnings Date and Information

Lexicon Pharmaceuticals last released its earnings data on March 11th, 2024. The biopharmaceutical company reported ($0.20) earnings per share for the quarter, beating the consensus estimate of ($0.23) by $0.03. The company had revenue of $0.70 million for the quarter, compared to analysts' expectations of $0.68 million. Lexicon Pharmaceuticals has generated ($0.80) earnings per share over the last year (($0.80) diluted earnings per share). Earnings for Lexicon Pharmaceuticals are expected to grow in the coming year, from ($0.71) to ($0.66) per share. Lexicon Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 7th, 2024 based off prior year's report dates.

Lexicon Pharmaceuticals Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/7/2024
Estimated)		------- 
3/11/2024Q4 2023($0.23)($0.20)+$0.03($0.20)$0.68 million$0.70 million
11/8/2023Q3 2023($0.22)($0.21)+$0.01($0.21)$1.49 million$0.16 million    
8/3/2023Q2 2023($0.17)($0.22)($0.05)($0.22)$0.30 million$0.32 million
5/2/2023Q1 2023($0.17)($0.17)-($0.17)-$0.02 million
3/2/2023Q4 2022($0.14)($0.16)($0.02)($0.16)-$0.03 million
11/9/2022Q3 2022($0.15)($0.13)+$0.02($0.13)-$0.04 million
8/2/2022Q2 2022($0.15)($0.16)($0.01)($0.16)-$0.04 million
5/5/2022Q1 2022($0.16)($0.16)-($0.16)-$0.04 million    
2/28/2022Q4 2021($0.17)($0.17)-($0.17)-$0.01 million    
11/3/2021Q3 2021($0.18)($0.16)+$0.02($0.16)-$0.02 million    
7/30/2021Q2 2021($0.16)($0.13)+$0.03($0.13)$0.03 million$0.23 million  
5/6/2021Q1 2021($0.17)($0.15)+$0.02($0.15)$3.35 million$0.03 million    

Lexicon Pharmaceuticals Earnings - Frequently Asked Questions

When is Lexicon Pharmaceuticals's earnings date?

Lexicon Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 7th, 2024 based off last year's report dates. Learn more on LXRX's earnings history.

Did Lexicon Pharmaceuticals beat their earnings estimates last quarter?

In the previous quarter, Lexicon Pharmaceuticals (NASDAQ:LXRX) reported ($0.20) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.23) by $0.03. Learn more on analysts' earnings estimate vs. LXRX's actual earnings.

How much revenue does Lexicon Pharmaceuticals generate each year?

Lexicon Pharmaceuticals (NASDAQ:LXRX) has a recorded annual revenue of $1.20 million.

How much profit does Lexicon Pharmaceuticals generate each year?

Lexicon Pharmaceuticals (NASDAQ:LXRX) has a recorded net income of -$177.12 million. LXRX has generated -$0.80 earnings per share over the last four quarters.

What is Lexicon Pharmaceuticals's EPS forecast for next year?

Lexicon Pharmaceuticals's earnings are expected to grow from ($0.71) per share to ($0.66) per share in the next year.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:LXRX) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!
Priority Gold
Can't believe it's happening again
Manward Press
This Apple-like Innovator is Revolutionizing Healthcare
Wall Street Star
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
The "Smart Money" Is Ready for May 1st Are You?
Stansberry Research
The “Perfect Storm” for Gold
Gold Safe Exchange
Top 5 AI Stocks to Buy for 2024
Market Moving Trends